Comprehensive Chromosome Screening (CCS) for Healthy Pregnancy

Comprehensive Chromosome Screening (CCS) analyzes embryos during IVF to identify chromosomal abnormalities, reducing miscarriage risk and improving implantation success. Women over 35 or with a history of multiple miscarriages can benefit most from this advanced fertility technology.

---

Key Takeaways

CCS Works in Conjunction with IVF for Chromosomal Testing

During IVF, blastocysts are cultivated and tested for chromosomal abnormalities before implantation. This process involves removing a small cell sample for analysis, ensuring only chromosomally healthy embryos are selected for transfer.

Ideal CCS Candidates Include Women Over 35 with Infertility Risks

Women aged 35+ or those with a history of early pregnancy loss, chromosomal abnormalities in previous pregnancies, or multiple failed IVF cycles are recommended for CCS to enhance pregnancy success rates.

CCS Reduces Risk of Chromosomal Disorders Like Down Syndrome

By identifying embryos with abnormal chromosome counts, CCS significantly lowers the likelihood of implantation failures and multiple pregnancies, as well as genetic conditions such as Down syndrome.

Embryo Freezing Allows Hormonal Balance Before Implantation

After CCS testing, embryos are cryopreserved to allow patients’ hormone levels to stabilize post-egg retrieval, creating an optimal uterine environment for successful implantation.

CCRM Fertility Offers Expert CCS Services for Customized Care

Clinics like CCRM provide compassionate, data-driven fertility care using CCS to address age-related infertility or recurrent pregnancy loss, offering personalized treatment options and emotional support.

---

Source: Read full article